Chemistry of hydrocarbon compounds – Unsaturated compound synthesis – Triple-bond product
Reexamination Certificate
1999-09-30
2001-09-11
Johnson, Jerry D. (Department: 1764)
Chemistry of hydrocarbon compounds
Unsaturated compound synthesis
Triple-bond product
C585S357000, C585S359000
Reexamination Certificate
active
06288297
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates generally to novel methods for the synthesis of cyclopropylacetylene which is an essential reagent in the asymmetric synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one; a useful human immunodeficiency virus (HIV) reverse transcriptase inhibitor. In the process, for example, cyclopropane carboxaldehyde is alkylated to form 1,1,1-trichloro-2-cyclopropyl-ethanol; which in turn is hydroxy protected to form 1,1,1-trichloro-2-cyclopropylthyltosylate; which in turn undergoes elimination to form cyclopropyl acetylene.
BACKGROUND OF THE INVENTION
Reverse transcription is a common feature of retrovirus replication. Viral replication requires a virally encoded reverse transcriptase to generate DNA copies of viral sequences by reverse transcription of the viral RNA genome. Reverse transcriptase, therefore, is a clinically relevant target for the chemotherapy of retroviral infections because the inhibition of virally encoded reverse transcriptase would interrupt viral replication.
A number of compounds are effective in the treatment the human immunodeficiency virus (HIV) which is the retrovirus that causes progressive destruction of the human immune system with the resultant onset of AIDS. Effective treatment through inhibition of HIV reverse transcriptase is known for both nucleoside based inhibitors, such as azidothymidine, and non-nucleoside based inhibitors. Benzoxazinones have been found to be useful non-nucleoside based inhibitors of HIV reverse transcriptase. The (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (VI):
is not only a highly potent reverse transcriptase inhibitor, it is also efficacious against HIV reverse transcriptase resistance. Due to the importance of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one as a reverse transcriptase inhibitor, economical and efficient synthetic processes for its production need to be developed.
Cyclopropylacetylene is an important reagent in the synthesis of compound (VI). Thompson et al,
Tetrahedron Letters
1995, 36, 937-940, describe the asymmetric synthesis of an enantiomeric benzoxazinone by a highly enantioselective acetylide addition followed by cyclization with a condensing agent to form the benzoxazinone shown below. As a reagent the cyclopropylacetylene was synthesized in a 65% yield by cyclization of 5-chloropentyne with n-butyllithiun at 0°-80° C. in cyclohexane followed by quenching with ammonium chloride. The process generates a low yield of cyclopropylacetylene which is not feasible for the large commercial process of a difficult to handle reagent.
Thompson et al, PCT International Patent Application Number WO 9622955 A1 describe an improved synthesis of cyclopropylacetylene useful in the synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one. Application WO 9622955 A1 discloses methods which continue to be inefficient in the overall synthesis on a kilogram scale for which this invention makes significant improvements.
The chemical literature shows the majority of the cyclopropylacetylene preparations involve the conversion of cyclopropylmethyl ketone to cyclopropyl-acetylene via the following chemical scheme. The method will produce cyclopropylacetylene on small scale, <1 kilogram, but is not amenable for bulk production, thus an alternative was developed.
The above methods for the synthesis of cyclopropylacetylene use combinations of toxic, difficult to handle reagents, relatively expensive materials, incomplete conversions and low yields which render the overall synthesis inefficient and yield cyclopropylacetylene of lower purity. Thus, it is desirable to discover new synthetic routes to cyclopropylacetylene on a large scale which improve upon these limitations and provide high yields of desired cyclopropylacetylene.
The present invention discloses a novel scalable procedure for the preparation of substituted acetylenes, more specifically cyclopropylacetylene. Improvements over previously disclosed preparations of cyclopropyl acetylene are in the low economic price and availability of the starting materials; the convenience and high yields for the chemistry; and the ability to crystallize and store without degradation the intermediates. The invention provides novel chemistry for the production of cyclopropyl acetylene from cyclopropane carboxaldehyde. The process provides a high yield (>90%) for the convenient reaction of cyclopropane carboxaldehyde with trichloroacetic acid to give 1,1,1-trichloro-2-cyclopropylethanol. The subsequent transformation of 1,1,1-trichloro-2-cyclopropylethanol to 1,1,1-trichloro-2-cyclopropyl-2-ethanyltosylate occurs in high yield using convenient reaction conditions. The final preparation of cyclopropylacetylene by dehalogenation from 1,1,1-trichloro-2-cyclopropyl-2-ethanyltosylate proceeds in high yields and with suitable purities so that the cyclopropyl acetylene produced and isolated can be stored or used as a solution in an inert solvent.
None of the above-cited references describe the methods of the present invention for the synthesis of substituted acetylenes, in particular, cyclopropylacetylene.
SUMMARY OF THE INVENTION
The present invention concerns an improved process suitable for the large scale preparation of cyclopropylacetylene. In the process, cyclopropane carboxaldehyde is condensed with an alkylating/halogenating agent, such as trichloroacetic acid, to form 1,1,1-trichloro-2-cyclopropyl-ethanol; 1,1,1-trichloro-2-cyclopropylethanol is protected to form 1,1,1-trichloro-2-cyclopropyl-2-ethanyltosylate; and 1,1,1-trichloro-2-cyclopropyl-2-ethanyltosylate is dehalogenated to form cyclopropyl acetylene. This improvement provides for high conversion of inexpensive, readily available starting materials into cyclopropyl acetylene, high overall yields and can be conducted on an industrial scale.
DETAILED DESCRIPTION OF THE INVENTION
In a first embodiment, the present invention provides a process for the preparation of compound of formula (IV);
wherein:
R
1
is selected from:
C
1-10
alkyl substituted with 0-3 R
4
,
C
2-6
alkenyl substituted with 0-1 R
4
,
C
3-10
cycloalkyl substituted with 0-2 R
5
,
C
3-6
carbocyclic ring substituted with 0-2 R
5
, and
aryl substituted with 0-2 R
6
;
R
4
, at each occurrence, is selected from OR
7
, NR
7
R
7a
, phenyl, and cyclopropyl;
R
5
, at each occurrence, is selected from D, methyl, ethyl, propyl, methoxy, ethoxy, and propoxy;
R
6
, at each occurrence, is selected from methyl, ethyl, propyl, methoxy, ethoxy, propoxy, F, Cl, B, I, CN, and NR
7
R
7a
;
R
7
and R
7a
are independently selected from methyl, ethyl, propyl, and butyl;
said process comprising:
(1) contacting an aldehyde of formula R
1
—CHO with trichloroacetic acid or tribromoacetic acid, in the presence of a base catalyst to form a compound of formula (II):
wherein R
2a
, R
2b
, and R
2c
are Cl or Br;
(2) contacting a compound of formula (II) with a hydroxy group protecting agent in the presence of a coupling catalyst and an acid scavenger, in a suitable nonaqueous solvent to form a compound of formula (III)
wherein —X′ is a hydroxy protecting group; and
(3) contacting a compound of formula (III) with a strong base to form a compound of formula (IV).
In a preferred embodiment, the present invention provides a process for the preparation of cyclopropylacetylene, said process comprising:
(1) contacting cyclopropane carboxaldehyde with trichloroacetic acid or tribromoacetic acid, in the presence of a base catalyst to form a compound of formula (IIa)
wherein R
2a
, R
2b
, and R
2c
are Cl or Br;
(2) contacting a compound of formula (IIa) with a sulfonyl hydroxy group protecting agent in the presence of a coupling catalyst and an acid scavenger, in a suitable nonaqueous solvent to form a compound of formula (IIIa)
wherein —SO
2
X is a sulfonyl hydroxy protecting group; and
(3) contacting a compound of formula (IIIa) with a strong
Campagna Silvio
Fortunak Joseph M.
Wang Zhe
Yin Jianguo
DuPont Pharmaceuticals Company
Johnson Jerry D.
LandOfFree
Process for the preparation of cyclopropylacetylene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of cyclopropylacetylene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of cyclopropylacetylene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2531520